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Abstract
Previous studies suggest white matter (WM) integrity is vulnerable to chronic hypoperfusion during brain ageing.
We assessed ~ 0.7 million capillary profiles in the frontal lobe WM across several dementias comprising Alzheimer’s
disease, dementia with Lewy bodies, Parkinson’s disease with dementia, vascular dementia, mixed dementias, post-
stroke dementia as well as post-stroke no dementia and similar age ageing and young controls without significant
brain pathology. Standard histopathological methods were used to determine microvascular pathology and
capillary width and densities in 153 subjects using markers of the basement membrane (collagen IV; COL4) and
endothelium (glucose transporter-1; GLUT-1). Variable microvascular pathology including coiled, tortuous, collapsed
and degenerated capillaries as well as occasional microaneurysms was present in all dementias. As expected, WM
microvascular densities were 20–49% lower than in the overlying cortex. This differential in density between WM
and cortex was clearly demonstrated by COL4, which was highly correlated with GLUT-1 densities (Spearman’s
rho = 0.79, P = 0.000). WM COL4 immunopositive microvascular densities were decreased by ~ 18% across the
neurodegenerative dementias. However, we found WM COL4 densities were increased by ~ 57% in post-stroke
dementia versus ageing and young controls and other dementias. Using three different methods to measure
capillary diameters, we found WM capillaries to be significantly wider by 19–45% compared to those in overlying
neocortex apparent with both COL4 and GLUT-1. Remarkably, WM capillary widths were increased by ~ 20% across
all dementias compared to ageing and young controls (P < 0.01). We also noted mean WM pathology scores
incorporating myelin loss, arteriolosclerosis and perivascular spacing were correlated with COL4 immunopositive
capillary widths (Pearson’s r = 0.71, P = 0.032). Our key finding indicates that WM capillaries are wider compared to
those in the overlying neocortex in controls but they dilate further during dementia pathogenesis. We suggest
capillaries undergo restructuring in the deep WM in different dementias. This reflects compensatory changes to
retain WM perfusion and integrity during hypoperfusive states in ageing-related dementias.
Keywords: Alzheimer’s disease, Dementia, Dementia with Lewy bodies, Microvascular pathology, Mixed dementia,
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Introduction
The cerebral white matter (WM) has become an import-
ant focus for investigation of mechanisms in brain age-
ing and dementia. Age is the single most important risk
factor for WM damage, which relates to increased white
matter hyperintensities (WMH) on T2- weighted mag-
netic resonance imaging (MRI) and associated with vas-
cular disease, disability, cognitive impairment and death
[9, 15, 18]. Cerebral hypoperfusion in older age is impli-
cated as a key pathophysiological element, which con-
tributes to diffuse WM changes. Both cerebral small
vessel disease and carotid artery disease are risk factors
for cerebral WM damage [4, 9]. WM vascular pathology
in brain ageing is observed with a frequency of 71% in
non-demented versus 84% in demented subjects [27].
WM vascular changes are most prominent in vascular
dementia [10]. However, all neurodegenerative demen-
tias bear some degree of vascular pathology ranging
from 61% in frontotemporal dementias to 82% in AD
[35]. A significant portion of such pathology is attributed
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to small vessel disease in the WM [10]. Previous imaging
and pathological studies indicated that the medullary arter-
ies and WM of the frontal lobe are especially susceptible
to haemodynamic derangement, leading to more severe
WM damage, than for example in the temporal lobe, dur-
ing ageing and vascular disease [13, 17]. Obstruction of
lumen at the proximal ends of penetrating arteries or be-
coming coiled or tortuous enroute would reduce blood
pressure and impact on perfusion of the WM [6]. Further-
more, age-related arteriosclerotic changes and segmental
loss of vascular smooth muscle cells along lengths of both
the medullary and perforating arteries disrupting flow in
the distal arteries and affecting perfusion of the deep WM
with the creation of an hypoxic environment [12, 26].
The microvascular network within the WM though
less dense than in the neocortex is equally vulnerable. In
ageing rats, primates and man endothelial cells of cor-
tical cerebral microvessels shrink with thickening of the
basal lamina [21, 24]. The endothelium is activated as
indicated by increased expression of the intercellular ad-
hesion molecule in relation to basement membrane
collagen IV (COL4) [12]. The activation is often accom-
panied by proliferation of microglia, which release prote-
ases and free radicals to promote damage to
components of the extracellular matrix that contain high
amounts of collagen [32]. The microvascular network
undergoes severe distortions including tortuosity, coiling
and kinking [6], which increase with age and coincides
with leukoaraiosis. Consistent with low tissue oxygen
tension, within the deep WM there is induction of
hypoxia-inducible factors 1alpha and 2alpha as well as key
hypoxia-regulated proteins such as matrix metalloprotein-
ase-7 and neuroglobin [12]. These observations are con-
sistent with elevated concentrations of the vasoconstrictor
endothelin 1, reflecting abnormal regulation of WM per-
fusion [5]. However, it is not clear at what threshold point
diffuse WM damage implied by the microvascular changes
tips over to affect cognitive function.
In this study, we focused on microvessels of the frontal
WM as a key component of the gliovascular unit facili-
tating tissue perfusion [16]. We concentrated on the
frontal lobe because of its contiguity with the centrum
semiovale region and relative vulnerability in cerebrovas-
cular disease [20, 21]. We specifically assessed capillary
changes in relation to WM damage across various neu-
rocognitive disorders including Alzheimer’s disease
(AD), dementia with Lewy bodies (DLB), Parkinson’s dis-
ease with dementia (PDD), Vascular dementia (VaD) as
well as post-stroke dementia (PSD).
Materials and methods
Study design and subjects
The study comprised 153 subjects derived from longitu-
dinal prospective dementia series and ageing controls
(Table 1). Dementia was clinically diagnosed and patho-
logically confirmed by post-mortem examination as ei-
ther AD, DLB, PDD, mixed DLB, PDD, AD and VaD
(who met two or more neuropathological diagnostic cri-
teria for DLB, PDD, AD and VaD) (Mixed 1), mixed
AD-VaD (Mixed 2), VaD or PSD. In addition, we com-
pared post-stroke no dementia (PSND) subjects as well
as young and ageing controls. The young control
subjects aged 55–68 and ageing control subjects aged
72–99 years were either participants in the previous pro-
spective studies [1] or were recruited based on unrelated
brain donations to the Newcastle Brain Tissue Resource
(NBTR). They were selected to be included as controls if
they had not been diagnosed with cognitive impairment
or any neurological or psychiatric illness or did not show
any signs of neurological disorders. The VaD, PSD and
PSND subjects were from the Newcastle Cognitive
Function After Stroke study [1]. Local research ethics
committees of the Newcastle upon Tyne NHS Founda-
tion Hospitals Trust granted ethical approvals. Permis-
sion for use of brains for post-mortem research was also
granted by consent from the individuals themselves
when they had been still alive or next-of-kin or family
member. All the brain tissues were retained and ob-
tained from the NBTR.
Brain tissues and neuropathological analysis
Neuropathological assessment was carried out as de-
scribed previously [1, 14]. Briefly, haematoxylin and
eosin (H&E) staining was used for assessment of
structural integrity and infarcts, Nissl and Luxol Fast
blue staining for cellular patterns and myelin loss,
Bielschowsky’s silver impregnation and amyloid-β for
Consortium to Establish a Registry for Alzheimer’s
Disease (CERAD) rating of neuritic plaques, Gallays
stain for neuritic pathology, and tau immunohistochem-
istry for Braak staging of neurofibrillary tangles [21, 22].
The clinical diagnoses of DLB and PDD were confirmed
according to established criteria [28]. The clinical diag-
nosis of AD was confirmed on evidence of significant
Alzheimer’s-type pathology, namely a Braak stage V–VI
score, a moderate-severe CERAD score [26] and an ab-
sence of significant vascular pathology. The clinical diag-
nosis of vascular dementia (VaD) was made when there
were multiple or cystic infarcts, lacunae, border-zone in-
farcts, microinfarcts and small vessel disease, and patho-
logically confirmed as Braak stage ≤ IV [21, 22]. Mixed
AD and VaD case was classified when there was suffi-
cient degree of pathology to reach Braak V–VI and sig-
nificant vascular pathology [3]. We also included cases
with Mixed dementia, who met two or more neuro-
pathological diagnostic criteria for DLB, PDD, AD and
VaD (Mixed 1) and AD-VaD (Mixed 2) (Table 1).
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Vascular pathology scores were derived from the pres-
ence of vascular lesions/pathologies in four brain areas,
including the frontal lobe at the level of the olfactory
bulbs, temporal lobe at level of the anterior hippocam-
pus, basal ganglia at level of mammillary body and mid-
dle segment of the hippocampus [10]. Lesions including
arteriolosclerosis, cerebral amyloid angiopathy, perivas-
cular haemosiderin leakage, perivascular space dilatation
in the deep and juxtacortical WM, myelin loss, and cor-
tical micro (< 0.5 cm) and large (> 0.5 cm) infarcts were
recorded with increasing severity resulting in greater
scores [10]. The relative presence of string and coiled
vessels was assessed in a semi-quantitative manner. WM
lesion (WML) scores were determined on scale of 0 to 3
signifying none, mild, moderate and severe. Previously,
we had shown there was 95% agreement in scoring be-
tween two assessors [10]. WM/vascular lesion severity
was graded from low to severe in quartiles essentially as
described previously [17]. All the vascular measures are
compatible with the recently established vascular cogni-
tive impairment neuropathology consortium criteria
[34]. Tissues from ageing control subjects had occasional
ageing-related pathology and were classified as ‘no
pathological diagnosis’ (Table 1). Except for neuropatho-
logical examination (RNK), all subsequent morphological
analyses were always undertaken under operator-blinded
conditions. Samples were identified with coded sequen-
tial numbers. In addition, at least two of both positive
and negative controls were included to monitor the
quality of staining.
Immunohistochemistry methods
Whole coronal sections at levels 6–8 [21, 31] containing
the frontal lobe (Brodmann area 9) were immunohisto-
chemically stained and analysed. Immunohistochemistry
for collagen IV (COL4), a marker of basement
Table 1 Demographic details, clinical and pathological features in cases used for microvascular quantification
Variable Young
Controls
Ageing
Controls
PSND AD DLB PDD Mixed 1 Mixed 2 VaD PSD
Number of subjects 9 16 18 18 16 13 17 14 13 19
Age, years, mean (range) 61.1↓
(55–68)*
86.9
(72–99)
84.7
(79–91)
87.8
(76–96)
79.6
(69–96)
72.8
(64–81)
83.0
(72–93)
84.7
(72–94)
88.1
(75–98)
87.5
(80–98)
Gender, number (F/M) 5 / 4 12 / 4 9 / 9 9 / 9 7 / 9 5 / 8 13 / 4 8 / 6 6 / 7 13 / 6
Total CAMCOG score (/100),
mean (range)
N/A N/A 88.0↑
(83–93)*
44.0
(20–73)
53.8
(24–80)
61.1
(39–74)
51.0
(23–68)
50.5
(41–61)
62.0
(25–80)
61.5
(24–80)
Memory sub-score (/27),
mean ± SEM
N/A N/A 21.4 ± 1.4↑* 10.0 ± 0.9 14.9 ± 1.1 16.2 ± 1.1 13.5 ± 1.6 N/A 14.4 ± 1.4 15.0 ± 2.2
Executive sub-score (/28),
mean ± SEM
N/A N/A 16.6 ± 1.2↑* 12.3 ± 0.6 12.1 ± 1.5 9.6 ± 0.9 11.2 ± 0.8 N/A 10.8 ± 1.2 11.1 ± 1.9
MMSE score (/30), mean (range) N/A N/A 27.3↑
(26–30)*
8.5
(0–16)
13.8
(6–20)
14.2
(3–20)
11.9
(2–19)
14.0
(12–16)
17.3↑
(8–24)¶
16.5
(12–20)
Braak Stage, mean (range) 0.25
(0–1)
1.9
(0–4)
2.6
(1–4)
5.6↑
(5–6)**
2.3
(0–4)
2.1
(0–4)
4.9↑
(2–6)**
5.2↑
(5–6)**
2.0
(0–4)
2.6
(1–4)
CERAD, mean (range) 0.0
(0–0)
0.5
(0–2)
1.7
(1–2)
2.9↑
(2–3)**
1.3
(0–3)
0.3
(0–2)
2.7↑
(0–3)**
2.9↑
(2–3)**
1.0
(0–2)
1.3
(1–3)
Vascular pathology score, mean
(range)♯
N/A 6.7↓
(0–10) ‡
13.5
(13–14)¶
10.8
(3–16)
9.6
(7–13)
9.8
(7–14)
10.6
(3–13)
11.0
(6–14)
13.2↑
(10–16)¶
13.3↑
(9–17)¶
WML score, mean (range) N/A 0.5↓
(0–2)§
2.5↑
(2–3)ψ
1.7
(0–3)
1.7
(1–3)
1.8
(1–3)
1.6
(0–3)
2.8↑
(2–3)ψ
2.9↑
(2–3)ψ
2.4↑
(2–3)ψ
White matter/Vascular lesions,
moderate - severe (%)
N/A 17.6↓** 100 72 75 92 88 95 100 100
Lewy body pathology,
number (limbic/neocortical)
0 / 0 0 / 0 0 / 0 0 / 1 3 / 11 3 / 7 3 / 5 0 / 0 4 / 0 0 / 0
Neuronal loss in substantia nigra,
number (none/mild/moderate/severe)
N/A N/A 18 / 0 / 0 / 0 7 / 8 / 2 / 0 0 / 3 / 6 / 6 0 / 1 / 2 / 9 3 / 4 / 7 / 2 14 / 0 / 0 / 0 7 / 4 / 2 / 0 19 / 0 / 0 / 0
Mixed dementia 1: 7 = AD+DLB, 6 = AD+VaD,
3 = AD+DLB + VaD and 1 = PDD + DLB + VaD; Mixed dementia 2: all with AD and VaD pathology
Age, *P < 0.01 vs Ageing Controls and all dementia groups; Total CAMCOG score, CAMCOG executive and memory sub-score and MMSE score, *P < 0.01 vs all
dementia groups;
Braak Stage, **P < 0.01 vs Young Controls, Ageing Controls, DLB, PDD and VaD; **P < 0.05 vs PSD and PSND; CERAD, **P < 0.01 vs Young Controls. Ageing Controls, DLB,
PDD, VaD, PSD and PSND
♯Vascular Pathology Score [10], ‡P < 0.01 vs all dementia groups; ¶P < 0.01 vs DLB and PDD; ¶P < 0.05 vs Mixed 1; WML score, §P < 0.01 vs all dementia groups; ψP < 0.01
vs AD, DLB, PDD and Mixed 1; White matter/Vascular lesions, moderate-severe (%) **P < 0.01 vs all dementia groups; Lewy body pathology, only the number of limbic/
neocortical cases are shown. Fourteen Ageing Controls, 15 AD, 6 Mixed 1, all Mixed 2, 9 VaD, all PSD and PSND cases had no Lewy body pathology. Two Ageing
Controls, 1 AD, 1 DLB and 2 Mixed 1 showed Lewy body pathology in brain stem. Data were not available for 1 case in DLB and PDD groups due to limited autopsy;
Neuronal loss in the substantia nigra, data was not available for 1 case in each group other than VaD, PSD and PSND due to limited autopsy
Abbreviations: AD Alzheimer’s disease, CAMCOG Cambridge Cognition Examination, CERAD Consortium to Establish a Registry for Alzheimer’s Disease, DLB Dementia
with Lewy Bodies, F female, M male, Mixed 1, Mixed dementia 1 with AD, DLB, PDD and VaD; Mixed 2, Mixed dementia 2 with AD and VaD, MMSE Mini Mental State
Examination, PDD Parkinson’s disease with dementia, PSD post-stroke dementia, PSND post-stroke no dementia, VaD Vascular dementia, WML white matter lesion
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membrane in the vessels and glucose transporter-1
(GLUT-1) or CD34, markers of endothelial cells were
performed to assess various microvascular structures
(Figs. 1 and 2). Tissue sections underwent antigen re-
trieval by using 12min heating in a microwave oven with
citrate buffer, pH 6.0 before being quenched with 3%
hydrogen peroxide in Tris-buffered saline (TBS). Sections
were then blocked with serum which was derived from
the species in which the secondary antibody was gener-
ated, for 30min. After the blocking processes, sections
were treated with the primary antibodies against COL4
(1:1000, Sigma) and GLUT-1 (1:200, Thermo Scientific) or
CD34 (1:1,000, Dako), 4 °C overnight followed by incuba-
tion with an appropriate secondary antibody (biotinylated
anti-IgG; 1:200, Vector Laboratories, USA) for 30min at
room temperature. Visualisation for standard colour im-
munohistochemistry was performed using the Vectastain
ABC System (Vector Laboratories) for 30min at room
temperature. After the final wash phase, the immunocom-
plexes were detected with diaminobenzidine (DAB).
Again, at least two of both positive and negative controls
were included to monitor the quality of staining.
Assessment of microvascular density
COL4 and GLUT-1 stained frontal lobe (Brodmann area
9) brain sections were analysed to assess microvascular,
predominantly capillary, density. A total of ~ 7000 im-
ages of stained sections were collected prior to analysis.
For each section, at least ten images from the entire
depth of the cerebral cortex and the deep WM (removed
from ventricular surfaces) were randomly captured using
a bright field microscope (Leitz DIALUX 20, Leica) with
a 10x objective lens coupled to an Infinity Capture2
camera running on Infinity Capture (Lumenera Corpor-
ation®) imaging software. Using image Pro Plus software
(V.6.3, Media Cybernetics, Silver Spring, MD, USA),
each image was traced and measured (pixels) to calcu-
late percentage of COL4-stained or GLUT-1-stained area
((pixels/pixels)*100, %) as a proxy for microvascular
density. We previously showed that estimation of micro-
vascular density by stained pixels was correlated with
manual count of microvessel length density (Lv) profiles
in serial sections [7]. Furthermore, vascular densities
assessed by COL4 and GLUT-1 staining in the WM and
cerebral cortex determined for each case were strongly
correlated with each other (Fig. 3).
Assessment of capillary width
Sections from the frontal (Brodmann 9) lobe were im-
munostained with COL4 and GLUT-1 (Brodmann area
9) and analysed to assess capillary widths. Capillaries
were carefully identified by their width, suggesting
Fig. 1 Methods used to quantify microvascular morphology a-d, Representative images of collagen-IV (COL4) stained microvessels in the cortex
(a, c) and WM (b, d). a-b, Screen shots of profiles of capillaries indicating how widths (diameters) were measured longitudinally using the VasCalc
method using 40x objective lens. c-d, Images of capillaries with indications (in green markers) where widths along the vessel were measured
using the Image-Pro Analyser method using 10x objective lens
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distinct absence of myocytes. We previously established
3-dimenstional stereology and 2-dimensional (2D)
methods were entirely consistent to quantify capillary
widths [7]. Here, we used 2D imaging to quantify capil-
lary widths from the immunostained sections containing
the WM and overlying cortex. In total, we analysed over
684,000 capillary profiles in frontal lobe serial sections
from 153 different dementia and control subjects. In most
cases, we analysed 100–190 capillaries from each WM
and cortical region. Longitudinally cut vessels were
preferred for measurement (Fig. 1). A centre measurement
with two other at the 1st and 4th quartiles were taken to
create a representative measurement. Any unusually large
(arteriole) or narrow vessel which appeared damaged was
avoided, including string vessels and vessels in which a
pericyte(s) was present. To make up to 100 profiles per
case, occasionally transversely, cut vessels were measured
in two dimensions and the mean diameter determined.
In preliminary experiments, we determined the best
method to assess capillary width of diameter by
Fig. 2 Microvascular pathology in the frontal WM in dementia a-h, Low and High power representative images of COL4 (a, b, c, e, g), GLUT-1
(d, f) and CD34 + COL4 (h) immunostained capillaries and microvessel in the WM. Collapsed and string vessels (arrows) were observed using both
markers in VaD and PSD with similar profiles in all dementias. e, a microaneurysm-like structure (arrow) in a PSD case detected using COL4. f, a
GLUT-1 immunmopostivie tortuous capillary (arrows) in AD. g, COL4 immunopositive ‘bagged’ vessel with increased perivascular space in a PSD
case. h, CD34 and COL4 positive profiles of arterioles and capillaries at the juxtaposition of the grey and WM showing several collapsed and
string capillaries (arrows). Scale bar represents 25 μm (a, b, c and d); 50 μm (e, f, and g); 100 μm (h)
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comparing three different methods vis a vis the ‘VasCalc’
method [37], Image-Pro Analyser method and manual
method. In the VasCalc method, the VasCalc software,
developed previously to measure sclerotic index as well
as diameters [37], was used to determine capillary width
or diameter of longitudinal microvessel profiles in three
different axes (Fig. 1). All width measurements were
taken from 40x magnification images. For the Image-Pro
Analyser, images taken at 10x magnification were used
to make three manual measurements per capillary pro-
file. The measurements then averaged to calculate mean
capillary diameter by converted the pixel values to μm
(*0.74). For the manual method, widths of capillary pro-
files in optically focused images taken at 25x magnifica-
tion were measured using a micro graticule. The
measured values in mm for each vessel were then con-
verted to μm using the formula 2 mm = 1 μm. Overall,
the three methods gave similar results. For example, the
mean capillary widths in WM or the cortex calculated
using the VasCalc software and Image-Pro Analyser
methods were not significantly different (P = 0.176,
Shapiro-Wilk for similar variances). The VasCalc was
Fig. 3 Quantification of microvascular density a, Typical images of COL4 immunostained capillaries in the cortex and WM used to quantify
densities. Scale bar represents 50 μm. b, Histogram showing microvascular densities in the WM and cortex in controls and different dementias. In
the WM, mean microvascular density was consistently lower by ~ 49% compared to cortex in all controls and dementia groups (§P < 0.01). In
different dementias, microvascular density in the WM was decreased by ~ 18% compared to ageing controls, particularly in PDD and Mixed
dementia 1 group (¶P < 0.05), whereas PSD and PSND showed ~ 57% higher microvascular density (#P < 0.012 vs all disease and control groups
other than PSND; †P < 0.025 vs all disease groups other than ageing controls, Mixed 2 and PSD). In the cortex, dementia subjects showed ~ 20%
lower vascular density compared with ageing controls, particularly in the PDD and Mixed dementia 1 group (*P < 0.05). Young control group
showed less vascular density by ~ 23% compared with ageing controls (‡P < 0.01). c, Correlation of microvascular densities between COL4 and
GLUT-1 immunostained areas in dementia subjects. Spearman’s correlation analysis revealed a strong positive correlation (rho = 0.79, P = 0.000)
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used as the method of choice to represent the results.
Unless otherwise stated, at least 18 images per case were
captured using Zeiss AxioPlan 2 microscope with
Plan-Neuofluar® objectives using the Infinity Capture2
camera running on Infinity Capture (Lumenera Corpor-
ation®) imaging software.
Statistical analysis
Statistical analysis was carried out using SPSS (IBM, ver-
sion 23.0, IBM Corporation, Armonk, NY, USA) with
the level of significance set at P < 0.05. First, distribution
of values was tested using the Shapiro-Wilk test
followed by one-way analysis of variance (one-way
ANOVA) with post-hoc Tukey’s tests for normally dis-
tributed values or Kruskall-Wallis H tests for
non-normally distributed values to compare data
amongst dementia and control groups. Student’s t-test
or Mann-Whitney U test was used for normally or
non-normally distributed data respectively to assess the
differences between cortex and WM data. Pearson’s cor-
relation analysis was performed for assessing correla-
tions between COL4 and GLUT-1 capillary width and
the relationship between mean COL4 width of each of
the disease groups and WM lesions derived from the
vascular pathology scores [10], as the data was normally
distributed. Spearman’s rho correlation analysis was used
to assess correlations between COL4 and GLUT-1 vas-
cular density, as the data was not normally distributed.
Results
Clinical and pathological features of the cases
Demographic details of the dementia subjects and con-
trols are shown in Table 1. The mean age of subjects was
not different between ageing controls and dementia
groups, whereas young controls obviously younger than
ageing controls and all dementia groups (*P < 0.01). The
total CAMCOG and MMSE scores indicated all subjects
had evidence of dementia at least 6 months prior to death.
There were no differences in CAMCOG scores including
memory and executive sub-scores and MMSE scores
amongst dementia groups. We further noted that 55% of
the dementia subjects exhibited hypertension (range
41–69% in each dementia group) and often had more than
one other vascular disease risk factor including diabetes
mellitus, ischaemic heart disease or smoking.
Neuropathological examination ensured appropriate
classification of the AD and Mixed cases with high Braak
and neuritic plaque scores. Lewy body counts and degree
of neuronal loss in the substantia nigra were used to
classify DLB and PDD cases. Notably, all dementias re-
vealed significantly high vascular pathology scores com-
pared to ageing controls (Table 1). The PSND subjects
as expected also showed high vascular pathology scores.
The WML scores were also significantly greater in all
the dementias and even higher in VaD, PSD and Mixed
2 cases compared to ageing controls. Compared to age-
ing controls, all dementia groups also exhibited moder-
ate to severe WM rarefaction and variable myelin loss
with mean WML scores of > 2 (prevalence of moderate
to severe white matter/vascular lesions) (Table 1).
Microvascular pathology in the WM
Conventional staining and immunohistochemistry with
COL4 and GLUT-1 antibodies revealed several abnor-
malities in microvessels of the deep WM across all de-
mentias (Fig. 2). As implied by the vascular pathology
scores (Table 1), we noted variable arteriolosclerosis,
hyalinisation, myelin loss, microinfarcts and perivascular
spacing with some vessels exhibiting fibroid necrosis and
occasionally microaneurysms. We also found tortuous or
coiled capillaries immunostained by both markers COL4
and GLUT-1. There were numerous collapsed or string
microvessels with absence of GLUT-1 immunoreactivity;
greater in some dementias than others (Fig. 2).
Semi-quantitative grading indicated the severity of string
capillaries or microvessels to be in the order: VaD =
PSD > AD >Mixed 2 >Mixed 1 ≥ DLB ≥ PDD > > Con-
trols. PSND had high number of string vessels but they
were less than those in PSD cases.
Microvascular density in the WM across the dementias
Quantification of COL4 immunostained microvessels
showed microvascular density in the deep WM was
lower by 20–49% compare to the entire depth of the
frontal cortex across all dementias, PSND and controls
(§P < 0.01) (Fig. 3a and b). The WM, except in PSD and
PSND subjects, generally showed ~ 18% lower micro-
vascular densities compared to ageing controls, particu-
larly in PDD and Mixed 1 dementia subjects (¶P < 0.05).
The PDD and Mixed 1 subjects also showed ~ 20%
lower cortical microvascular densities compared to age-
ing controls (*P < 0.05) (Fig. 3b). In PSD, WM but not
cortical microvascular densities were higher by 14%
compared to those in PSND subjects. Microvascular
density was greater by ~ 23% in the cortex in ageing
controls compared to young controls (‡P < 0.01). We
further demonstrated that microvascular densities were
similarly altered retaining the trends in changes when
GLUT-1 was used as the endothelial cell marker. Lower
GLUT-1 densities were evident in the WM compared to
cortex whereas the % GLUT-1 immunostained area in
both the WM and cortex showed a strong positive cor-
relation in dementia and ageing controls (Spearman’s
rho = 0.79, P = 0.000) (Fig. 3c). In keeping with this cal-
culation, the mean ratios of GLUT-1:COL4 in ageing
controls in the WM was 0.8 whereas that in the cortex
was 0.75 (P > 0.05). These ratios were not significantly
changed in either VaD or AD subjects (data not shown).
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Capillary width in the WM in dementia
We first quantified widths of frontal WM and cortical
capillaries labelled by COL4 and GLUT-1 immunoreac-
tivities in control subjects (Fig. 4). We found that mean
capillary widths assessed by COL4 and GLUT-1 were
positively correlated in the cortex and the WM (Pear-
son’s r = 0.64, P = 0.001) (Fig. 4b). The dot plot indicated
the capillary widths in the WM were greater compared
to the cortex. In further quantitative analysis of COL4
immunostained capillaries across all dementias and con-
trols, we confirmed that the WM capillaries exhibited
wider widths by ~ 31% compared to the cortex in all
subjects (§P < 0.01) (Fig. 4a and c). However, surprisingly
we found that the capillaries in the WM were marginally
but significantly wider (**P < 0.01) in all dementias irre-
spective of type compared to ageing and young controls
(Fig. 4c). In the cortex, the capillaries in dementia subjects
were not significantly wider compared with the controls,
but AD group showed significantly wider capillaries com-
pared to controls (†P < 0.01) (Fig. 4c).
To test whether WM capillary changes were related to
ensuing WM pathology, we plotted mean values of capil-
lary widths from different dementia groups and ageing con-
trols against WML scores (Fig. 5). We found a moderate
correlation indicating greater capillary width was associated
with greater WML scores (Pearson’s r = 0.71, P = 0.032).
Fig. 4 Quantification of capillary width a, Representative images of COL4 immunostained capillaries in the cortex and WM used to determine
capillary width. Scale bar represents 25 μm. b, Correlation of mean capillary widths assessed by COL4 and GLUT-1 immunostaining in ageing
controls. Pearson’s analysis revealed that mean capillary width in both the WM and the cortex was positively correlated (r = 0.64, P = 0.001).
c, Histogram showing mean capillary width in the WM and cortex in controls and dementia groups. In the WM, mean capillary width was
consistently larger by 19–45% compared to cortex in all control and dementia groups (§P < 0.01). In all the dementias, capillary width in the WM
was consistently greater by < 20% compared to ageing and young controls (**P < 0.01). In the cortex, mean capillary widths in dementia subjects
were not significantly wider compared with ageing and young controls, but only AD subjects showed wider capillaries compared with ageing
and young controls (†P < 0.01)
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Discussion
Analyses of different dementias using repeated robust
methods of quantification in a large series of samples in-
dicate several novel observations related to microvessels,
largely capillaries of the WM compared to those of the
cortex in ageing brain. We first report high degree of
SVD pathology and capillary abnormalities in the WM
in clinically assessed subjects with different neurodegen-
erative dementia diagnoses including DLB, PDD, Mixed
dementias and AD. This was corroborated by the vascu-
lar pathology as well as WML scores. Whereas the high-
est burden of SVD pathology [29] consisting of severe
arteriolosclerosis, WM rarefaction, microinfarction and
perivascular spacing was present in VaD and PSD, it was
intriguing that subjects diagnosed with neurodegenera-
tive dementias including PDD, DLB and AD exhibited
similar SVD changes. Arteriolosclerosis and microin-
farcts, which are strongly associated with cognitive im-
pairment [2, 20, 36], were consistent features in different
dementia types. Capillary abnormalities including tortu-
ous or coiled capillaries as well as collapsed string ves-
sels were evident particularly in VaD and PSD cases,
suggesting cerebral hypoperfusion or ischaemic changes
are likely the cause of microvascular abnormalities.
While these microscopic lesions are not apparent on
T2-weighted or FLAIR sequences from MRI [8, 9], they
demonstrate they are present in tissue and may contrib-
ute to overall dementia diagnoses.
Quantification of microvascular pathology in the WM
across the neurodegenerative dementias showed total
COL4 immunopositive microvascular densities tended
to be decreased by ~ 18% although they were increased
by 52% in PSD compared to VaD subjects. We suggest
the SVD type of pathological changes, particularly in the
vascular dementias, reflects restructuring of the micro-
vascular network by increasing capillary bed to counter
hypoperfusion in the WM. Our results also suggest that
subjects with more chronic state disease e.g. VaD versus
PSD exhibit lower degrees of microvascular plasticity.
When capillaries lose their endothelium by chronic cere-
bral hypoperfusion or ischaemic insults, the basement
membrane is not degraded and form functionally useless
string vessels that can no longer transport cells or
plasma [6]. Previous results show that 3 to 5 days after
ischaemic insults, capillaries lose endothelial cells pre-
senting accordion-like pleating of residual basement
membrane and leading to thin acellular strands at 40 days
post insult. Since some string vessels were found in ageing
controls although to a much lesser extent than in all de-
mentias with extracellular pathology [6, 23], it suggests
nominal vascular remodeling or restructuring also occurs
in normal ageing brain. String vessel remnants can pro-
vide the skeletal structure for newly forming capillaries by
invading capillaries forming new basement membrane
within the old, presenting a duplicated basement mem-
brane [6]. The basement membrane provides the support-
ing structure of a microvessel composed of several thin
layers of insoluble extracellular proteins including collagen
(50%) and the framework for growth of endothelial cells
[30] and restoring the gliovascular unit [16].
Fig. 5 Relationship between WM capillary width and WM pathology Plot shows correlation between mean capillary widths assessed by COL4
immunostaining in all the dementias and ageing controls versus WML scores. Pearson’s analysis revealed that mean capillary width in the WM in
dementia was positively correlated with WM damage (r = 0.71, P = 0.032). Although there were some age-related changes in WM in the controls,
it was clear that all dementias were a disparate group as a whole exhibiting high WML scores and wider capillaries
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Our results showed that both in controls (physio-
logical) and pathological conditions, capillary width was
consistently larger by ~ 45% whereas microvascular
density was lower by ~ 49% in the WM compared to the
cortex. In other words, capillaries in the WM were wider
and sparse, whereas capillaries in the cortex were nar-
rower and dense. These observations were verified by a
correlation analysis of the two markers, COL4 as well as
GLUT-1. The strong positive correlation between micro-
vascular width assessed by COL4 and GLUT-1 con-
firmed that the size of entire capillary including the
vascular lumen is larger in the WM compared to the
cortex and this was increased by ~ 20% in dementia
states. The robustness of these observations was
strengthened by our previous studies [7] reporting
strong correlation between COL4 and GLUT-1 immuno-
stained microvascular length densities (Lv) in the hippo-
campus (r2 = 0.687, P = 0.000). We similarly noted that
capillary widths in the WM of the temporal lobe were
larger by 17–20% than those in the overlying cortex (P <
0.01) and in dementia subjects including VaD, Mixed
and AD (P < 0.01) compared to controls (unpublished
results). The WM versus cortical or gray matter differ-
ences in microvascular densities [25] and capillary sizes
appear specific and likely reflect cellular contents of the
regions. Protection of neurons in the cortex requires
greater supply of oxygen and nutrients reflecting higher
microvascular densities whereas blood flow per unit
length of WM capillary is increased. While similar con-
clusions may be made for GLUT-1 results as those for
COL4, these novel findings with respect to dementia
suggest there are compensatory mechanisms in the WM
to maintain reserves of blood flow within capillaries and
ameliorate cerebral hypoperfusion [11, 16]. It is plausible
that capillary dilation with the reflected structural modi-
fications leads to a local increase in the number of eryth-
rocytes of ~ 6 μm in diameter travelling in a single file
[33] as an adaptive mechanism to increase oxygen sup-
ply in the chronically hypoxic deep WM [12]. That WM
capillaries also tended to be increased in width in the
PSND subjects suggested it was the presence of vascular
pathology in the WM that likely instigates widening of
the capillaries. However, we cannot refute that the wider
vascular width in the cortex evident in AD or Mixed de-
mentia subjects could be due to microangiopathy attrib-
uted to amyloid or other proteins, particularly adhering
to capillaries [19].
We emphasise that one of the main limitations of our
study is that brain regions other than the frontal lobe
were not systematically investigated for SVD pathology.
We also did not quantify the densities of string or coiled
vessels across all dementias. This is an extremely cum-
bersome undertaking and we deemed it would not im-
prove the outcomes over the semi-quantitative results
presented. While we concentrated on the deep WM of
the frontal lobe in accord with our prior hypothesis [16],
we had previously demonstrated the spectrum of SVD
pathology in different dementias including VaD, AD and
DLB incorporating the temporal lobe and the basal gan-
glia [10]. Given that the same neurodegenerative path-
ologies occur in PDD and other mixed dementias, it is
reasonable to suggest similar microvascular or capillary
changes occur in the WM of these dementias. Quantifi-
cation of capillary widths in more regions of the brain
can also be quite cumbersome. Still we deem such an
undertaking in the future would inform on the relative
degrees of microvascular abnormalities in different de-
mentias, as assessment of microvascular abnormalities
potentially distinguish dementias with more severe vas-
cular insults (such as VaD and PSD) from other neuro-
degenerative dementias.
Conclusions
In summary, we provide evidence for widespread micro-
vascular pathology in the frontal WM relative to the cor-
tex in neurodegenerative as well as dementias caused by
vascular disease. We also showed that capillaries of the
deep WM have greater diameters compared to the over-
lying neocortex and that capillary width sizes are in-
creased in different dementias. Our results imply
chronic hypoperfusion induces microvascular modifica-
tion or restructuring in the deep WM that may affect
the function of the gliovascular unit and WM perfusion.
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